Malcolm Moore

Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada.

The Vancouver Prostate Centre provides prostate cancer research, treatment, and education services. Its comprehensive, in-house research program ranges from molecular biology to functional genomics, and encompasses active clinical trials, socio-behavioral studies and research into complementary and alternative medicine. The company was founded in 1998 and is headquartered in Vancouver, Canada.

PC-TRiADD is a translational research program. It also offers pharmaceutical and biotech companies, as well as external researchers, integrated translational research services such as drug discovery, preclinical testing, tumour biology and clinical research. The company is headquartered in Vancouver, Canada.

Sustained Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in an undisclosed location. Sustained Therapeutics is developing a sustained-release drug delivery platform for managing acute and chronic pain. The Canadian company is currently conducting clinical trials for ST-01, their innovative sustained-release form of Lidocaine, for various pain indications. Patients can join their trials to experience the benefits of sustained-release Lidocaine today. The company was founded by Martin E. Gleave.

Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada.

Rocket Gold Corp. engages in the acquisition and exploration of mineral properties. It holds interests in the Titan Property. The company was founded on November 26, 2019 and is headquartered in Vancouver, Canada.